Charleston, S.C. (April 21, 2026) – The Association for Clinical and Translational Science (ACTS), a non-profit membership of translational scientists from the nation’s leading academic medical centers, honored its Translational Science Award recipients at Translational Science 2026. At this year’s annual event, ACTS named MUSC clinical psychologist Lindsay Squeglia, Ph.D., among the recipients of the 2026 ACTS Award for Supporting an Excellent Translational Science Workforce.
Squeglia holds many influential roles, both in her clinical work, where she focuses on substance use and prevention and its effect on adolescent brain development, and in the mentoring space. She is the clinical and scientific advisor for the “Just Say Know” school-based substance use prevention program and co-leads the Translational Workforce Development program at the South Carolina Clinical & Translational Research (SCTR) Institute. As co-director of the MUSC Youth Collaborative, Squeglia has mentored more than 100 trainees, from high school students to junior faculty members. “My goal is reducing barriers and individualizing mentorship so that we can capitalize on those strengths and help people reach their goals,” she said.
These awards recognize investigators for their outstanding contributions to clinical research and the translational science field. Individuals and teams are nominated by their colleagues and peers and may be selected from all industry segments.
"The ACTS awards recognize talented investigators who translate their findings from the bench to bedside and ultimately into the community. Awardees are in all phases of studies and disciplines throughout the workforce, which includes investigators, trainees, educators and research teams. These award winners and their work represent the values and mission of ACTS for innovation, team science and community involvement, applying principles of translational science,” said ACTS President Allan R. Brasier, M.D.
The ACTS Award for Supporting an Excellent Translational Science Workforce was created to recognize individuals who, through their careers of mentoring, policymaking or team building have contributed to a more excellent translational science workforce.
###
The Association for Clinical and Translational Science (ACTS) uniquely provides an outstanding platform for enhancing education, research, and public policy related to clinical and translational science. ACTS members consist of leaders, investigators, and trainees from academic medical centers, government, industry, and philanthropy. ACTS focuses on four realms: research, education, advocacy, and mentoring. Additional information is available at the ACTS website at www.actscience.org.
About MUSC
Founded in 1824 in Charleston, MUSC is the state’s only comprehensive academic health system, with a mission to preserve and optimize human life in South Carolina through education, research and patient care.
Each year, MUSC educates nearly 3,500 students in six colleges and trains approximately 1,050 residents and fellows across its health system. MUSC leads the state in federal, National Institutes of Health and other research funding. For information on our academic programs, visit musc.edu.
As the health care system of the Medical University of South Carolina, MUSC Health is dedicated to delivering the highest-quality and safest patient care while educating and training generations of outstanding health care providers and leaders to serve the people of South Carolina and beyond. In 2025, for the 11th consecutive year, U.S. News & World Report named MUSC Health University Medical Center in Charleston the No. 1 hospital in South Carolina. To learn more about clinical patient services, visit muschealth.org.
MUSC has a total enterprise annual operating budget of $8.9 billion. The nearly 35,000 MUSC members include world-class faculty, physicians, specialty providers, scientists, contract employees, affiliates and care team members who deliver groundbreaking education, research and patient care.